Open AccessPentoxifylline improves the quality of life in type-2 diabetes foot syndrome
Author(s) -
Marwan S.M. Al-Nimer,
Rawa Ratha,
Taha Othman Mahwi
Publication year - 2019
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.35.5.11
Subject(s) - medicine , pentoxifylline , type 2 diabetes , diabetic foot , foot (prosody) , diabetes mellitus , endocrinology , linguistics , philosophy
To evaluate the effect of pentoxifylline on the quality of life (QoL) in diabetic foot syndrome (DFS) by using Short Form-36 questionnaire, and in reference to the revised neuropathy disability score (RNDS) and grading of diabetic foot.